Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Certain drugs that block specific enzymes can help treat prostate diseases.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Muscles can make their own androgens, which may help muscle growth.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

A natural steroid in the body may protect against eye damage in glaucoma.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride can cause serious side effects in some men, needing more research for treatment.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.